Director, Brain Science Institute NeuroTranslational Drug Discovery Program
Dr. Slusher is a Professor of Neurology, Psychiatry, and Neuroscience and the Director of the Brain Science Institute NeuroTranslational Drug Discovery Program at the Johns Hopkins School of Medicine. At Hopkins she leads the largest integrated drug discovery program on campus, responsible for translating basic science discoveries into new drug therapies for neurological and psychiatric disorders. Her 20-member veteran drug discovery team consists of medicinal chemists, assay developers, pharmacologists, toxicologists, and pharmacokinetic/drug metabolism experts.
Prior to joining Hopkins in 2010, Dr. Slusher had a highly accomplished drug discovery career in the pharmaceutical industry holding positions of increasing responsibility at ICI Pharmaceuticals, Zeneca (now Astra-Zeneca), Guilford Pharmaceuticals, MGI Pharma, and the Eisai Research Institute, including several years as Senior Vice President of Research and Translational Development. Her experience in drug discovery spans through Phase I/IIa clinical development, participation in multiple FDA meetings and both IND and NDA regulatory filings. She has been involved in the successful development, launch and/or post marketing support of 4 branded medicines.
Dr. Slusher is an inventor of over fifty issued patents and applications and has published over 140 scientific articles, reviews and book chapters. She has been an invited speaker at many national and international scientific meetings and has served on the advisory board or as a scientific consultant of several biopharma companies. She has co-founded a new biotechnology company in Baltimore called Cerecor, to commercialize JHU drug discovery inventions. She is also leading the first International Consortium for Academic Drug Discovery scientists in an effort to coordinate and enhance university-led drug discovery efforts.
Dr. Slusher received her undergraduate degree from Dickinson College where she graduated valedictorian, majoring in Chemistry. She received her Ph.D. in Pharmacology and Molecular Sciences from John Hopkins School of Medicine while simultaneously earning her Master's degree in Administrative Science from Johns Hopkins Carey School of Business (formerly the Hopkins' School of Continuing Studies).